Mucpharm Pty Ltd
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nebulised BromAc in Healthy Volunteers (NCT05220605) | Mucpharm Pty Ltd | 2022-07-27 |
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei (NCT03976973) | Mucpharm Pty Ltd | 2022-05-01 |
| Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease (NCT05258682) | Mucpharm Pty Ltd | 2022-05-01 |
Track Mucpharm Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.